Results 61 to 70 of about 6,862 (171)

AI in Mental Health: Transforming Diagnosis and Management of Depression and Anxiety

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Introduction Mental health disorders, especially depression and anxiety, are major contributors to the global disease burden. Traditional psychiatric methods can be time‐consuming and often struggle with accurate diagnosis and effective treatment. Artificial intelligence (AI) has the potential to improve diagnostic precision and streamline the
Tilyan Kambar, Sara Tariq, Saman Shahzad, Hajra Sana Sultan, Araj Naveed Siddiqui, Fakiha Ahmed Shah, Hamna Khanani, Ayesha Khan, Hussain Haider Shah, Sameer Abdul Rauf, Muhammad Abdul Wasay Zuberi, Radeyah Waseem, Muhammad Sheheryar Hussain, Md Ariful Haque   +13 more
wiley   +1 more source

The Evolutionary Biology of Female‐Biased Pain and Its Disorders

Evolutionary Applications, Volume 19, Issue 4, April 2026.
ABSTRACT This article describes and evaluates a general evolutionary theory for explaining variation among individuals in sensitivity to pain, the Vulnerability‐Value‐Opportunity model. The model posits that pain sensitivity is mediated by vulnerability to fitness‐reducing injury (probabilities of damage, including from infection), Fisherian ...
Bernard Crespi
wiley   +1 more source

Game Changers in the Treatment of and Engagement With Persons Living With Mental Health and Substance Use Disorders: The Role of the Nurse

International Journal of Mental Health Nursing, Volume 35, Issue 2, April 2026.
ABSTRACT The game changers in mental health and substance use disorder treatment have been shaped by historical sea changes marked by transformative advancements that have significantly enhanced patient care. Breakthroughs in psychotherapy, psychosurgery and psychopharmacology have each contributed to reshaping clinical practices, especially the ...
Arlene Kent‐Wilkinson, Sudor Ogunwemimo, Eileen Zaba   +2 more
wiley   +1 more source

A baseline audit of opiate substitution therapy and 12-week retention in treatment

European Psychiatry, 2007
Background:The National Treatment Agency has set 12-week retention as an outcome measure for the treatment of opiate addiction. Both methadone and buprenorphine show research evidence of efficacy in this condition. To ensure that these medications are being used optimally, we performed a baseline audit in two drug treatment services in North East ...
A. Akioye, R. Cohen
openaire   +1 more source

Evaluation of Sociodemographic Determinants in Narcotic Users Referring to Center for Methadone Maintenance Therapy of Yazd, Iran

Journal of Community Health Research, 2012
Introduction: Addiction is a habit or behavior that is often hard to quit. It is estimated that 190 million persons are substance users around the world. Substance abuse creates tolerance after a while.
M.H. Lotfi, M.R Vafaeinasab, M. Alimi, F. Beyzi   +3 more
doaj  

Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder

Substance Abuse and Rehabilitation, 2023
Nicholas L Bormann,1 Andrea N Weber,2,3 Benjamin Miskle,2,4 Stephan Arndt,2,5 Alison C Lynch2,6 1Psychiatry and Psychology, Mayo Clinic Health System, Albert Lea, MN, USA; 2Psychiatry, University of Iowa, Iowa City, Iowa, USA; 3Internal Medicine ...
Bormann NL, Weber AN, Miskle B, Arndt S, Lynch AC   +4 more
doaj  

Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP

Health and Quality of Life Outcomes, 2018
Background Economic evaluation normally requires information to be collected on outcome improvement using utility values. This is often not collected during the treatment of substance use disorders making cost-effectiveness evaluations of therapy ...
Jasmine Peak, Ilias Goranitis, Ed Day, Alex Copello, Nick Freemantle, Emma Frew   +5 more
doaj   +1 more source

Factors Influencing Sexual Dysfunction in Men Receiving Opioid Substitution Therapy in a Portuguese Center

Gazeta Médica
Introduction: We intended to assess the prevalence of sexual dysfunction in men receiving opioid substitution therapy in a Portuguese center, which domains of sexual function are affected, and which factors influence sexual dysfunction.
Tânia Patrícia Vasques Alves, Patrícia Jorge de Azevedo Barbosa Silveira Machado Freitas   +1 more
doaj   +1 more source

Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study

BJGP Open
Background: Women who use drugs face specific challenges compared with men such as higher rates of HIV infection, unsafe injecting practices, and intimate partner violence (IPV).
Daniela S Goeieman, Robert Mash, Natasha R Gloeck, Andrew Scheibe   +3 more
doaj   +1 more source

Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice

Harm Reduction Journal, 2019
Background Opioid dependence, characterised by socio economic disadvantage and significant morbidity and mortality, remains a major public health problem in Ireland. Through the methadone treatment protocol (MTP), Irish general practice has been a leader
Ide Delargy, Des Crowley, Marie Claire Van Hout   +2 more
doaj   +1 more source